Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_assertion type Assertion NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_head.
- NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_assertion description "[IL-10 antibodies were assayed in patients diagnosed with chronic and acute infectious mononucleosis (CIM, AIM), nasopharyngeal carcinoma (NPC), and EBV-associated lymphoproliferative disease (LPD), as well as from healthy organ transplant patients and EBV-negative or EBV-positive persons.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_provenance.
- NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_assertion evidence source_evidence_literature NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_provenance.
- NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_assertion SIO_000772 9395354 NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_provenance.
- NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_assertion wasDerivedFrom befree-20150227 NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_provenance.
- NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_assertion wasGeneratedBy ECO_0000203 NP505295.RAUjXR2u1w8ChwyzYVsfRXns5v79_Flf4lbxu3EsiLvpA130_provenance.